JP Morgan Chase
MYOK

JP Morgan Chase’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

JP Morgan Chase’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$1.56M – 6014
2019
Q3 		$1.56M Buy
+30,000
New +$1.6M ﹤0.01% 3568

JP Morgan Chase's MYOK Position: Q4 2020 in Review

JP Morgan Chase sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 425,628 shares — an estimated $57.1M sold.

JP Morgan Chase first reported a position in MYOK in Q1 2016 and held it in 19 quarters. The position peaked at $57.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • JP Morgan Chase reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 425,628 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $57.1M.
  • JP Morgan Chase first reported a position in MyoKardia, Inc. Common Stock in Q1 2016 and held it in 19 quarters.
  • JP Morgan Chase's MyoKardia, Inc. Common Stock position peaked at $57.1M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.